Advancing Commercial Models in Life Sciences: Improving Treatment Adherence with Digital, Data-Driven Experiences
The effects of most drug therapies are invisible to patients, who may eventually stop taking them – in fact, adherence to chronic medication is about 50% globally. Solving the issues of compliance and adherence requires drug companies to reframe how they engage patients as consumers and help them understand and recognize the value of treatment. A … Read more